Design, synthesis, and evaluation of indanone derivatives as acetylcholinesterase inhibitors and metal-chelating agents

Bioorg Med Chem Lett. 2012 Jul 1;22(13):4462-6. doi: 10.1016/j.bmcl.2012.04.029. Epub 2012 Apr 13.

Abstract

A series of novel indanone derivatives was designed, synthesised and evaluated as potential agents for Alzheimer's disease. Among them, compound 6a, with a piperidine group linked to indone by a two-carbon spacer, exhibited the most potent inhibitor activity, with an IC(50) of 0.0018 μM for AChE; the inhibitory activity of this compound was 14-fold more potent than that of donepezil. Furthermore, these compounds also exhibited good metal-chelating ability.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylcholinesterase / chemistry*
  • Acetylcholinesterase / metabolism
  • Alzheimer Disease / drug therapy
  • Chelating Agents / chemical synthesis*
  • Chelating Agents / chemistry
  • Chelating Agents / therapeutic use
  • Cholinesterase Inhibitors / chemical synthesis*
  • Cholinesterase Inhibitors / chemistry
  • Cholinesterase Inhibitors / therapeutic use
  • Drug Design*
  • Humans
  • Indans / chemical synthesis*
  • Indans / chemistry
  • Indans / therapeutic use
  • Kinetics
  • Metals / chemistry*
  • Pyridines / chemical synthesis*
  • Pyridines / chemistry
  • Pyridines / therapeutic use
  • Structure-Activity Relationship

Substances

  • Chelating Agents
  • Cholinesterase Inhibitors
  • Indans
  • Metals
  • Pyridines
  • indacrinone
  • Acetylcholinesterase